![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 20, 18408-18418, May 16, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Accumulation of the amyloid-
Transforming Growth Factor-
1 Potentiates
Amyloid-
Generation in Astrocytes and in Transgenic Mice*
**,
§**,
,
,
,
,
,
,
**, and
**
Unité Mixte de Recherche (UMR)
CNRS 6551, IFR47, Université de Caen, Cyceron, Caen Cedex 14074, France, ¶ Department of Psychiatry, Institute of Psychiatric
Research, Indiana University School of Medicine, Indianapolis, Indiana
46202, and
Unité INSERM 422, Vieillissement
Cérébral et Dégénérescence Neuronale,
Lille Cedex 59045, France
peptide (A
) in
the brain is crucial for development of Alzheimer's disease.
Expression of transforming growth factor-
1 (TGF-
1), an
immunosuppressive cytokine, has been correlated in vivo
with A
accumulation in transgenic mice and recently with A
clearance by activated microglia. Here, we demonstrate that TGF-
1
drives the production of A
40/42 by astrocytes leading to A
production in TGF-
1 transgenic mice. First, TGF-
1 induces the
overexpression of the amyloid precursor protein (APP) in astrocytes but
not in neurons, involving a highly conserved TGF-
1-responsive
element in the 5'-untranslated region (+54/+74) of the APP promoter.
Second, we demonstrated an increased release of soluble APP-
which
led to TGF-
1-induced A
generation in both murine and human
astrocytes. These results demonstrate that TGF-
1 potentiates A
production in human astrocytes and may enhance the formation of plaques
burden in the brain of Alzheimer's disease patients.
*
This work was supported to grants from the Regional Council
of Lower Normandy (to S. L.), the French Ministry of Research and Technology (to G. L.), the National Center for Scientific Research CNRS (to C. G.), and the National Institutes of
Health (to D. K. L.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.

To whom correspondence should be addressed: UMR CNRS 6551, Université de Caen, Centre Cyceron, Boulevard Henri Becquerel, BP
5229, Caen Cedex 14074, France. Tel.: 33-2-3156-6039; Fax: 33-2-3156-6199; E-mail: d.vivien@neuro.unicaen.fr.
This article has been cited by other articles:
![]() |
L. Desire, J. Bourdin, N. Loiseau, H. Peillon, V. Picard, C. De Oliveira, F. Bachelot, B. Leblond, T. Taverne, E. Beausoleil, et al. RAC1 Inhibition Targets Amyloid Precursor Protein Processing by {gamma}-Secretase and Decreases A{beta} Production in Vitro and in Vivo J. Biol. Chem., November 11, 2005; 280(45): 37516 - 37525. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hashimoto, T. Chiba, M. Yamada, M. Nawa, K. Kanekura, H. Suzuki, K. Terashita, S. Aiso, I. Nishimoto, and M. Matsuoka Transforming Growth Factor {beta}2 Is a Neuronal Death-Inducing Ligand for Amyloid-{beta} Precursor Protein Mol. Cell. Biol., November 1, 2005; 25(21): 9304 - 9317. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Hamaguchi, S Okino, N Sodeyama, Y Itoh, A Takahashi, E Otomo, M Matsushita, H Mizusawa, and M Yamada Association of a polymorphism of the transforming growth factor-{beta}1 gene with cerebral amyloid angiopathy J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 696 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. Lee, J. L. Kang, and Y. H. Chong The Amyloid-{beta} Peptide Suppresses Transforming Growth Factor-{beta}1-induced Matrix Metalloproteinase-2 Production via Smad7 Expression in Human Monocytic THP-1 Cells J. Biol. Chem., March 4, 2005; 280(9): 7845 - 7853. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sung, H. Yang, K. Uryu, E. B. Lee, L. Zhao, D. Shineman, J. Q. Trojanowski, V. M.-Y. Lee, and D. Pratico Modulation of Nuclear Factor-{kappa}B Activity by Indomethacin Influences A{beta} Levels but Not A{beta} Precursor Protein Metabolism in a Model of Alzheimer's Disease Am. J. Pathol., December 1, 2004; 165(6): 2197 - 2206. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Sortino, M. Chisari, S. Merlo, C. Vancheri, M. Caruso, F. Nicoletti, P. L. Canonico, and A. Copani Glia Mediates the Neuroprotective Action of Estradiol on {beta}-Amyloid-Induced Neuronal Death Endocrinology, November 1, 2004; 145(11): 5080 - 5086. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. De Pietri Tonelli, M. Mihailovich, A. Di Cesare, F. Codazzi, F. Grohovaz, and D. Zacchetti Translational regulation of BACE-1 expression in neuronal and non-neuronal cells Nucleic Acids Res., March 19, 2004; 32(5): 1808 - 1817. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Mousseau, S. Chapelsky, G. De Crescenzo, M. D. Kirkitadze, J. Magoon, S. Inoue, D. B. Teplow, and M. D. O'Connor-McCourt A Direct Interaction between Transforming Growth Factor (TGF)-{beta}s and Amyloid-{beta} Protein Affects Fibrillogenesis in a TGF-{beta}Receptor-independent Manner J. Biol. Chem., October 3, 2003; 278(40): 38715 - 38722. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |